MedTrace Logo

The Ghana Breast Health Study

NCT01661023 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4241

Last updated 2020-04-20

No results posted yet for this study

Summary

Background:

\- Breast cancer is becoming more common in Africa. A higher number of cases appear in women under age 35 than in the developed world. However, little is known about the factors that may contribute to breast cancer in Africa. Researchers want to collect information from female patients in teaching hospitals in Accra and Kumasi, Ghana and to compare this information with that obtained from healthy women in the general population. These two hospitals treat most breast cancers in Ghana. The data will provide information regarding factors that predispose to the development of breast cancer among women in Ghana.

Objectives:

\- To identify and study breast cancer risk factors in women in Ghana.

Eligibility:

* Women between 18 and 74 years of age who are diagnosed with breast cancer.
* Participants will come from teaching hospitals in Accra and Kumasi, Ghana. Women without breast cancer will be identified from the 2010 Ghanaian Census for comparison purposes

Design:

* Participants will answer questions about their health and lifestyle.
* Height, weight, and waist/hip measurements will be collected.
* Blood and saliva samples will be collected.
* Participants will be given a collection kit to collect a stool sample.
* Treatment will not be provided as part of this study.

Conditions

  • Breast Neoplasms

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Montserrat Garcia-Closas, M.D. · National Cancer Institute (NCI)

Eligibility

Min Age
18 Years
Max Age
74 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-19
Primary Completion
2016-04-25
Completion
2020-04-16

Countries

  • Ghana

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01661023 on ClinicalTrials.gov